- Home
- DD vs GEHC Comparison
DD vs GEHC Comparison
Compare DD & GEHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DD
- GEHC
- Stock Information
- Founded
- DD 2015
- GEHC 1892
- Country
- DD United States
- GEHC United States
- Employees
- DD N/A
- GEHC N/A
- Industry
- DD Major Chemicals
- GEHC Computer Software: Prepackaged Software
- Sector
- DD Industrials
- GEHC Technology
- Exchange
- DD Nasdaq
- GEHC Nasdaq
- Market Cap
- DD 34.2B
- GEHC 28.1B
- IPO Year
- DD N/A
- GEHC N/A
- Fundamental
- Price
- DD $66.75
- GEHC $69.87
- Analyst Decision
- DD Buy
- GEHC Strong Buy
- Analyst Count
- DD 14
- GEHC 10
- Target Price
- DD $84.36
- GEHC $88.80
- AVG Volume (30 Days)
- DD 3.2M
- GEHC 6.0M
- Earning Date
- DD 05-02-2025
- GEHC 04-30-2025
- Dividend Yield
- DD 2.46%
- GEHC 0.20%
- EPS Growth
- DD N/A
- GEHC 38.77
- EPS
- DD N/A
- GEHC 4.76
- Revenue
- DD $12,521,000,000.00
- GEHC $19,799,000,000.00
- Revenue This Year
- DD $6.04
- GEHC $3.77
- Revenue Next Year
- DD $4.54
- GEHC $4.61
- P/E Ratio
- DD N/A
- GEHC $14.69
- Revenue Growth
- DD 4.51
- GEHC 1.56
- 52 Week Low
- DD $53.77
- GEHC $57.65
- 52 Week High
- DD $90.06
- GEHC $94.80
- Technical
- Relative Strength Index (RSI)
- DD 52.27
- GEHC 51.08
- Support Level
- DD $64.09
- GEHC $66.95
- Resistance Level
- DD $68.37
- GEHC $71.21
- Average True Range (ATR)
- DD 1.72
- GEHC 2.19
- MACD
- DD 0.74
- GEHC 1.06
- Stochastic Oscillator
- DD 78.34
- GEHC 76.96
About DD DuPont de Nemours Inc.
DuPont is a diversified global specialty chemicals company created in 2019 as a result of the DowDuPont merger and subsequent separations. Its portfolio includes specialty chemicals and downstream products that serve the electronics, water, construction, safety and protection, automotive, and healthcare industries. DuPont plans to spin off its electronics business by the end of 2025.
About GEHC GE HealthCare Technologies Inc.
GE HealthCare Technologies is a leading medical technology firm with leading market share in imaging and ultrasound equipment. The company reports four major segments: imaging (45% of revenue), advanced visualization solutions (26%), patient care solutions (16%), and pharmaceutical diagnostics (13%). The company's sales are geographically diverse, with the United States, EMEA, China, and the rest of the world accounting for 46%, 26%, 12%, and 17% respectively. We estimate approximately half of its revenue is recurring, which consists of servicing (about one third of revenue), pharmaceutical diagnostics (about 10%-15%), and digital solutions (just over 5%).